Machine Learning Approach Based on Echocardiographic Data to Improve Prediction of Cardiovascular Events in Hypertrophic Cardiomyopathy
Conditions: Hypertrophic Cardiomyopathy Sponsors: Pr. Nicolas GIRERD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor
Conditions: Sleep-Disordered Breathing; Sleep Architecture; Arrhythmia Interventions: Device: Belun Ring; Device: Belun Cor Sponsors: Belun Technology Company Limited; University Hospitals Cleveland Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Instructional Design and Implementation for Educational Skills Program Based on Constructivist Learning Approach
Conditions: Teacher Training Interventions: Other: Education Sponsors: Istanbul University - Cerrahpasa (IUC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania
DiscussionInnovative strategies that recognize the dynamic process of lifelong retention in HIV care are urgently needed. Strategies such as conditional economic incentives are a simple and effective method for improving many health outcomes, including those on the HIV continuum. If coupled with other supportive services such as home visits (phase 1) or with tailored counselling (phase 2), economic incentives have the potential to strengthen engagement among the subpopulation of PLHIV who struggle with retention in care and could help to close the gap towards reaching global “95–95-95” goals for ending the AIDS epide...
Source: Trials - February 10, 2024 Category: Research Source Type: clinical trials
Interference During Motor Learning of Different Degrees of Freedom in the Paretic Upper Extremity of People With Stroke
Conditions: Stroke Interventions: Behavioral: Training Sponsors: University of Valencia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)
Conditions: Limb-girdle Muscular Dystrophy Interventions: Biological: SRP-9003; Drug: Glucocorticoid Sponsors: Sarepta Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
SWITCH Diets Study: Self-monitoring With Internet Technology to Choose Healthy Diets
Conditions: Overweight and Obesity; Pre-diabetes Interventions: Behavioral: learning modules (within app); Behavioral: SWITCH app (self-regulation features) - Experimental; Behavioral: SWITCH app (self-regulation features) - Comparator Sponsors: University of South Carolina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Super-fast 3T Prostate MRI Using High Gradient Strength and Deep Learning
Conditions: Prostate Cancer Interventions: Device: MRI of the prostate Sponsors: University Hospital, Bonn Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Use Electroencephalogram to Study Neural Dynamics of Fear Conditioning and Avoidance Learning Circuit in Humans
Conditions: Neural Dynamics of the Acquisition and Retention of Fear Learning and Active Avoidance Learning Interventions: Behavioral: Conditioning and active avoidance paradigm (CAAP) Sponsors: The University of Texas Health Science Center, Houston Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Trial to Learn How REGN5381 Works and How Safe it is in Adults With Heart Failure With Reduced Ejection Fraction (HFrEF)
Conditions: Heart Failure Interventions: Drug: REGN5381; Drug: Placebo Sponsors: Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
Conditions: Influenza, Human, SARS-CoV-2 Infection, COVID-19 Interventions: Biological: BNT162b2 (Omi XBB.1.5)/RIV; Biological: BNT162b2 (Omi XBB.1.5); Biological: RIV; Other: Normal saline placebo Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Effect of Intelligent Tutor Induced Pausing on Learning Simulated Surgical Skills
Conditions: Surgical Education Interventions: Behavioral: Experimental Group ICEMS verbal feedback with pause group; Behavioral: Experimental Group ICEMS audio feedback with pause and expert video Sponsors: McGill University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
A Mechanistic Trial of the Neurobiology of Extinction Learning and Intraparietal Sulcus Stimulation
Conditions: Posttraumatic Stress Disorder Interventions: Device: Continuous Theta Burst Stimulation to the Intraparietal Sulcus; Device: Sham Continuous Theta Burst Stimulation Sponsors: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
Conditions: B-Cell Non-Hodgkin Lymphoma (B-NHL) Interventions: Drug: Odronextamab; Drug: Ifosfamide; Drug: Carboplatin; Drug: Etoposide; Drug: Rituximab; Drug: Dexamethasone; Drug: Cisplatin; Drug: Cytarabine; Drug: Gemcitabine Sponsors: Regeneron Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Effectiveness and brain mechanism of multi-target transcranial alternating current stimulation (tACS) on motor learning in stroke patients: study protocol for a randomized controlled trial
This study aims to ascertain whether multi-target tACS is more effective than single-target stimulation in stroke patients and to further explore the potential underlying brain mechanisms by using techniques such as transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI).MethodsThis study employs a double-blind, sham-controlled, randomized controlled trial design with a 2-week intervention period. Both participants and outcome assessors will remain unaware of treatment allocation throughout the study. Thirty-nine stroke patients will be recruited and randomized into three distinct groups, including the...
Source: Trials - January 30, 2024 Category: Research Source Type: clinical trials
